Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.

Online event: A disruptive solution for poor drug solubility

| Medlemsnyhet | Företag Zerion Pharma A/S

Meet Zerion Pharma's management – ​​CEO Ole Wiborg who will run through the investment proposal and business case.

The company aims to make a real difference in health care with its Dispersome® technology in relation to the formulation of new and existing drugs. Poor drug solubility is one of the main reasons for drug development failure. ZERION has a solution - Dispersome® - a technology that increases the chance of success for new drug development, allows for improvement of existing drugs enabling more new drugs to reach the market, and leads to improved treatment of patients as well as reduced toxic waste. The Dispersome® technology makes it possible to reduce the number of active drugs by up to 75%

It is an online event taking place on 15 March, 13:00 - 13:30.  

Register by clicking on the link: https://www.inderes.dk/videos/zerion-pharma-a-disruptive-solution-for-poor-drug-solubility


Zerion Pharma A/S

Fruebjergvej 3
2100 Copenhagen
Zerion Pharma A/S

Sänd till en kollega